VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

The 2022 Tandem Meetings | Highlights from the Tandem Meetings: new promising CAR-T constructs

Manali Kamdar, MD, University of Colorado Cancer Center, Aurora, CO, shares her highlights from the 2022 Tandem Meetings, discussing updates in CAR-T constructs for both non-Hodgkin and Hodgkin lymphoma, as well as trends in the use of autologous transplantation and CAR-T therapy. This interview took place at the Transplantation & Cellular Therapy (TCT) Meetings of ASTCT™ and CIBMTR® 2022 in Salt Lake City, Utah.

Disclosures

Research Support/Funding: TG Therapeutics, Genentech, Novartis
Consultancy: AbbVie, AstraZeneca, Celgene/ Bristol-Myers Squibb, Adaptive Biotechnologies, ADC therapeutics, Beigene, Genentech, Impact bio
Speaker’s bureau: SeaGen
DMC: Celgene , Genentech

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter